1. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
- Author
-
Manuela Argentini, Isabelle Delumeau, Bohdan Wasylyk, Roberto Salvi, Laurent Debussche, Christine Dureuil, Joseph Abecassis, and Christine Wasylyk
- Subjects
Cancer Research ,Programmed cell death ,Cell cycle checkpoint ,Tumor suppressor gene ,Cell Survival ,Molecular Sequence Data ,Biology ,Proto-Oncogene Proteins ,Tumor Cells, Cultured ,Genetics ,Humans ,E2F1 ,Amino Acid Sequence ,E2F ,neoplasms ,Molecular Biology ,Cell Death ,Effector ,Cell Cycle ,Nuclear Proteins ,Proto-Oncogene Proteins c-mdm2 ,Apoptosis ,Cell culture ,Cancer research ,Tumor Suppressor Protein p53 ,HeLa Cells - Abstract
The p53 tumour suppressor is frequently inactivated in human tumours. One form of inactivation results from overexpression of MDM2, that normally forms a negative auto-regulatory loop with p53 and inhibits its activity through complex formation. We have investigated whether disrupting the MDM2-p53 complex in cells that overexpress MDM2 is sufficient to trigger p53 mediated cell death. We find that expression of a peptide homologue of p53 that binds to MDM2 leads to increased p53 levels and transcriptional activity. The consequences are increased expression of the downstream effectors MDM2 and p21WAF1/CIP1, inhibition of colony formation, cell cycle arrest and cell death. There is also a decrease in E2F activity, that might have been due to the known physical and functional interactions of MDM2 with E2F1/DP1. However, this decrease is p53 dependent, as are also colony formation, cell cycle arrest and cell death. These results show that a peptide homologue of p53 is sufficient to induce p53 dependent cell death in cells overexpressing MDM2, and support the notion that disruption of the p53-MDM2 complex is a target for the development of therapeutic agents.
- Published
- 1999
- Full Text
- View/download PDF